Log in to save to my catalogue

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mi...

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2299135444

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study

About this item

Full title

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European archives of psychiatry and clinical neuroscience, 2020-06, Vol.270 (4), p.471-482

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Brain-derived natriuretic factor (BDNF) Val66Met polymorphism has been frequently reported to be associated with Alzheimer’s disease (AD) with contrasting results. Numerous studies showed that Met allele increased the risk of AD only in women, while other studies have found worse cognitive performance in Val/Val carriers. We aimed to inquire the ef...

Alternative Titles

Full title

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2299135444

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2299135444

Other Identifiers

ISSN

0940-1334

E-ISSN

1433-8491

DOI

10.1007/s00406-019-01069-y

How to access this item